Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours
- 1 September 2010
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 11 (9), 871-879
- https://doi.org/10.1016/s1470-2045(10)70034-6
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancerAnnals of Oncology, 2009
- Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case reportAnti-Cancer Drugs, 2008
- A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignanciesNeuro-Oncology, 2008
- Chemotherapy in neoplastic meningitisCritical Reviews in Oncology/Hematology, 2006
- Intrathecal topotecan in adult patients with neoplastic meningitisAmerican Journal of Health-System Pharmacy, 2006
- Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumabThe Lancet Oncology, 2006
- Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitisCancer, 2006
- The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised studyEuropean Journal Of Cancer, 2004
- Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary reportJournal of Neuro-Oncology, 1995
- Leukoencephalopathy and Elevated Levels of Myelin Basic Protein in the Cerebrospinal Fluid of Patients with Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1980